We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Global Breast Imaging Market Worth USD 4.6 Billion by 2023

By MedImaging International staff writers
Posted on 06 Feb 2019
Print article
The global breast imaging market is projected to grow at a CAGR of 8.0% from USD 3.1 billion in 2018 to reach USD 4.6 billion by 2023, driven mainly by technological advancements and rising incidence of breast cancer. The market growth will be further aided by the rising adoption of advanced techniques for breast cancer screening and increasing government and private investments for improving breast cancer care.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company. On the basis of technology, the ionizing breast imaging technology segment is expected to account for the largest share of the breast imaging market during the forecast period, primarily due to technological advancements in ionizing breast imaging technologies and rising awareness about early screening and diagnosis of breast cancer. Based on type, the 3D breast tomosynthesis segment is expected to register the highest CAGR during the forecast period, driven by the growing demand for advanced screening technologies and increasing regulatory approvals for 3D breast tomosynthesis systems.

Geographically, North American accounted for the largest share of the global breast imaging market in 2018, due to rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), and rapidly increasing geriatric population in the region.

Related Links:
MarketsandMarkets

New
MRI Infusion Workstation
BeneFusion MRI Station
New
Biopsy Software
Affirm® Contrast
Portable Color Doppler Ultrasound System
S5000
3T MRI Scanner
MAGNETOM Cima.X

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more